# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA802289 | F | Inhibition of TNF and IL-1 induced IL-6 production in human chondro-sarcoma SW 1353 cells | Homo sapiens | 14 | ALA1133482 | cell-based format | Scientific Literature | |
2. | ALA802290 | F | Inhibition of TNF and IL-1 induced IL-6 production in human chondro-sarcoma SW 1353 cells at 2.5 uM | 8 | ALA1133482 | cell-based format | Scientific Literature | ||
3. | ALA806235 | F | TNF-alpha-induced IL-6 production in SW1353 cells | Homo sapiens | 14 | ALA1135137 | cell-based format | Scientific Literature | |
4. | ALA806236 | F | Compound was evaluated for its ability to inhibit IL-6 production in SW1353 cells treated with cytokines IL-1 and TNF | Homo sapiens | 3 | ALA1133306 | cell-based format | Scientific Literature | |
5. | ALA806237 | F | Inhibition of IL-6 production by SW1353 cells treated with both cytokines IL-1 and TNF-alpha. | Homo sapiens | 11 | ALA1134054 | cell-based format | Scientific Literature | |
6. | ALA891128 | F | Inhibition of IL-1-beta-induced MMP13 production in human SW1353 cells at 50 uM | Homo sapiens | 4 | ALA1147035 | cell-based format | Scientific Literature | |
7. | ALA1057902 | F | Antiinflammatory activity in PMA-stimulated human SW1353 cells assessed as inhibition of NF-kappaB activation | Homo sapiens | 4 | ALA1152395 | cell-based format | Scientific Literature | |
8. | ALA1058703 | A | Cytotoxicity against human SW1353 cells by neutral red assay | Homo sapiens | 16 | ALA1152395 | cell-based format | Scientific Literature | |
9. | ALA2019906 | A | Cytotoxicity against human SW1353 cells after 30 mins by ATP-dependent luciferase luminescence assay | Homo sapiens | 26 | ALA2016522 | cell-based format | Scientific Literature | |
10. | ALA2019986 | F | Inhibition of IL1beta-stimulated MMP13 secretion in human SW1353 cells incubated for 30 mins prior to IL1beta-stimulation measured after 24 hrs by ELISA | Homo sapiens | 1 | ALA2016522 | cell-based format | Scientific Literature | |
11. | ALA2389962 | T | Toxicity in human SW1353 cells | Homo sapiens | 1 | ALA2384992 | cell-based format | Scientific Literature | |
12. | ALA3129455 | F | Antiproliferative activity against human SW1353 cells assessed as growth inhibition at 10 uM after 48 hrs by MTT assay | Homo sapiens | 2 | ALA3124810 | cell-based format | Scientific Literature | |
13. | ALA3270647 | F | Cytotoxicity against human SW1353 cells after 48 hrs by MTT assay | Homo sapiens | 1 | ALA3259795 | cell-based format | Scientific Literature | |
14. | ALA4012930 | F | Growth inhibition of human SW1353 cells harboring Wnt or BRCA1/2 mutant after 6 days in presence of 1% FBS by Cell-Titer Glo assay | Homo sapiens | 1 | ALA4011625 | cell-based format | Scientific Literature | |
15. | ALA4012959 | F | Growth inhibition of human SW1353 cells harboring Wnt or BRCA1/2 mutant at 10 uM after 6 days in presence of 1% FBS by Cell-Titer Glo assay relative to control | Homo sapiens | 1 | ALA4011625 | cell-based format | Scientific Literature | |
16. | ALA4012982 | F | Growth inhibition of human SW1353 cells harboring Wnt or BRCA1/2 mutant after 6 days in presence of 10% FBS by Cell-Titer Glo assay | Homo sapiens | 1 | ALA4011625 | cell-based format | Scientific Literature | |
17. | ALA4013010 | F | Growth inhibition of human SW1353 cells harboring Wnt or BRCA1/2 mutant at 10 uM after 6 days in presence of 10% FBS by Cell-Titer Glo assay relative to control | Homo sapiens | 1 | ALA4011625 | cell-based format | Scientific Literature | |
18. | ALA5156015 | F | Antiproliferative activity against human SW1353 cells assessed as cell growth inhibition measured after 72 hrs by CCK-8 assay | Homo sapiens | 3 | ALA5154661 | cell-based format | Scientific Literature |